Using early blood test to predict pregnancy complications
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at a blood test done early in pregnancy (NIPT) to see if it can help predict conditions like preeclampsia, preterm labor, or gestational diabetes. If you had this test and had a healthy pregnancy or one of these complications, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby (not twins or more)
- You had a non-invasive prenatal test (NIPT) at 9 to 13 weeks of pregnancy, and the results were low-risk
- Your NIPT blood sample is still stored at the lab
- You either had a healthy pregnancy that went to at least 37 weeks, or you were diagnosed with preeclampsia, preterm labor (PPROM), or gestational diabetes
- You do not have a history of certain health problems like diabetes or high blood pressure before pregnancy, or any major uterine issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is checking if certain proteins in your blood (called placental growth factor and nucleosomes) during early pregnancy can help predict problems like preeclampsia or preterm birth. If you join, you'll give a blood sample during your regular NIPT test, and researchers will follow your pregnancy to see how it goes.
This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This study follows pregnant people to better understand pregnancy complications like high blood pressure and gestational diabetes. You may be asked to provide regular health information and possibly samples to help researchers learn what affects you and your baby.
This study looks at a new blood test to screen for single-gene disorders (conditions caused by changes in one gene) during pregnancy. It may help if you or your baby's father carry a genetic disorder, or if an ultrasound shows signs of a possible genetic condition.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.